The FDA has categorized this as a Class I recall, meaning the use of these devices could cause “serious injuries or death.”

Opill (norgestrel) is a progestin-only daily oral contraceptive that can be purchased without prescription at drug stores, convenience stores, grocery stores and online once it becomes available to consumers.

Healthcare providers might be the most underrated of all AI stakeholders. Never mind that close to half of 200 CEOs surveyed believe healthcare is the field in which AI is likely to make the most transformative contribution.

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. 

In a July 6 announcement, CMS shared that coverage is officially available for Leqembi for those who meet certain criteria.

The proposed rule would require that short-term plans are truly short-term and are active for just three months.

The estimated increase is driven by multiple factors, including labor shortages, provider contract negotiations and rising drug prices.

The upcoming changes include a total of 395 new codes, 25 deletions and 13 revisions.